NCCN announces the appointment of Russell W. Budd, president and
managing shareholder of Baron & Budd, P.C., to the NCCN Foundation Board
of Directors, the philanthropic affiliate of NCCN chaired by ABC news
veteran, Sam Donaldson.
FORT WASHINGTON, Pa.--(BUSINESS WIRE)--The National Comprehensive Cancer Network® (NCCN®)
welcomes Russell W. Budd, president and managing shareholder of Baron &
Budd, P.C., as the newest member to Board of the NCCN
Foundation, the philanthropic affiliate of NCCN. The NCCN Foundation
seeks support for programs to benefit patients with cancer as well as
clinical researchers.
“I am honored that the NCCN Foundation has made
the visionary step of inviting an attorney to serve on their board and
hopeful that together we can address the many needs of cancer patients.”
“Mr. Budd is an exceptional addition to the NCCN Foundation Board,” said
Patricia J. Goldsmith, Executive Vice President and COO, NCCN. “His
esteemed reputation and ongoing commitment to patients with cancer and
their families complement the mission of the NCCN Foundation to provide
resources to improve the lives of patients with cancer. We are honored
that he is willing to add his expertise to our current board, and we
look forward to working with him on a number of initiatives.”
Mr. Budd has been a shareholder of Baron
& Budd since 1985 and president and managing shareholder since
2002. Over the last decade, Mr. Budd has played a significant role in
protecting the rights of people injured by exposure to asbestos.
Although the practice has expanded its scope to include cases as diverse
as asbestos exposure, water contamination, Gulf Oil spill damages,
unsafe pharmaceuticals, securities fraud and commercial litigation, Mr.
Budd remains dedicated to protecting the rights of people who suffer
from cancers like mesothelioma and lung cancer, which are often
attributable to environmental toxins.
Under Mr. Budd’s direction, the firm has given generously to a number of
asbestos awareness advocacy organizations as well as providing a
cornerstone donation to the International Pleural Mesothelioma Program
at Brigham & Women’s Hospital to research curative mesothelioma.
“Given the complexity of today’s cancer care and new research emerging
in the field, this board has the tremendous opportunity to educate
people with cancer, such as mesothelioma, about their treatment
options,” said Mr. Budd. “I am honored that the NCCN Foundation has made
the visionary step of inviting an attorney to serve on their board and
hopeful that together we can address the many needs of cancer patients.”
Mr. Budd’s philanthropic endeavors continue outside of the firm as he
and his wife are very involved in the community and are passionate
supporters of Habitat for Humanity in the Dallas area. A father of two,
he is active in his church and in his children’s many activities.
The NCCN
Foundation was created to advance the NCCN mission of improving the
quality and effectiveness of care provided to patients with cancer,
while providing additional information and resources for informed
decision-making. One of the primary initiatives of the NCCN Foundation
is to gain support for the distribution of the NCCN
Guidelines for Patients™. The NCCN Guidelines for Patients™
are translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN
Guidelines™) into patient-friendly language outlining
appropriate treatments.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®),
a not-for-profit alliance of 21 of the world’s leading cancer centers,
is dedicated to improving the quality and effectiveness of care provided
to patients with cancer. Through the leadership and expertise of
clinical professionals at NCCN Member Institutions, NCCN develops
resources that present valuable information to the numerous stakeholders
in the health care delivery system. As the arbiter of high-quality
cancer care, NCCN promotes the importance of continuous quality
improvement and recognizes the significance of creating clinical
practice guidelines appropriate for use by patients, clinicians, and
other health care decision-makers. The primary goal of all NCCN
initiatives is to improve the quality, effectiveness, and efficiency of
oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Comprehensive Cancer
Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center |
Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer
Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA;
Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT;
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance,
Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns
Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of
Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer
Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute,
Tampa, FL; The Ohio State University Comprehensive Cancer Center - James
Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell
Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at
Barnes-Jewish Hospital and Washington University School of Medicine, St.
Louis, MO; St. Jude Children’s Research Hospital/University of Tennessee
Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center,
Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer
Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer
Center, San Francisco, CA; University of Michigan Comprehensive Cancer
Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical
Center, Omaha, NE; The University of Texas MD Anderson Cancer Center,
Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.
Clinicians, visit NCCN.org.
Patients and caregivers, visit NCCN.com.
Contacts
NCCN
Megan Martin, 215-690-0576
martin@nccn.org
No comments:
Post a Comment